Bayer oral anticoagulant Xarelto has gained positive common drug review (CDR) recommendation from the Canadian Agency for Drugs and Technologies in Health for the prevention of stroke and systemic embolism in atrial fibrillation (AF) ...
Tags: Bayer oral anticoagulant Xarelto, CDR Recommendation, Stroke Prevention